The healthcare sector has experienced a groundbreaking advancement in diabetes management with the arrival of copyright. This transformative medication, classified as a glucagon-like peptide-1 (GLP-1) receptor agonist, offers a novel approach to controlling blood sugar levels in individuals with typ